NASDAQ : GRI
GRI Bio, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.53 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.34M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 5.61M | 5.16M | 4.47M | 8.15M | 2.00M | 813.00K |
| Research & Development | 4.07M | 6.82M | 3.77M | 3.23M | 242.00K | 249.00K |
| Other Operating Expenses | -250.00K | |||||
| Operating Expenses | 9.68M | 11.98M | 8.23M | 11.14M | 2.24M | 1.06M |
| Operating Income | -9.68M | -11.98M | -8.23M | -11.14M | -2.24M | -1.06M |
| Interest Expense | -2.08M | -653.00K | -547.00K | |||
| Interest & Investment Income | 19.00K | 21.00K | 25.00K | |||
| Other Non Operating Income (Expenses) | 3.00K | 182.00K | ||||
| EBT Excluding Unusual Items | -9.66M | -11.96M | -8.21M | -13.04M | -2.89M | -1.61M |
| Other Unusual Items | -325.00K | 50.00K | ||||
| Pretax Income | -9.66M | -11.96M | -8.21M | -13.04M | -3.22M | -1.56M |
| Net Income | -9.66M | -11.96M | -8.21M | -13.04M | -3.22M | -1.56M |
| Preferred Dividends & Other Adjustments | 1.91M | |||||
| Net Income to Common | -9.66M | -11.96M | -10.12M | -13.04M | -3.22M | -1.56M |
| Shares Outstanding (Basic) | 835.97K | 98.16K | ||||
| Shares Outstanding (Diluted) | 835.97K | 98.16K | ||||
| EPS (Basic) | -11.55 | -121.80 | ||||
| EPS (Diluted) | -11.55 | -121.80 | ||||
| Free Cash Flow | -10.42M | -10.19M | -8.61M | -9.00M | -1.09M | -847.00K |
| Free Cash Flow Per Share | -12.46 | -103.80 | ||||
| EBITDA | -9.68M | -11.97M | -8.23M | -11.13M | -2.24M | -1.06M |
| D&A For EBITDA | 3.00K | 4.00K | 4.00K | 4.00K | 3.00K | 3.00K |
| EBIT | -9.68M | -11.98M | -8.23M | -11.14M | -2.24M | -1.06M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 10.95M | 8.23M | 5.03M | 1.81M | 9.00K | 90.00K |
| Cash & Short-Term Investments | 10.95M | 8.23M | 5.03M | 1.81M | 9.00K | 90.00K |
| Prepaid Expenses | 387.00K | 363.00K | 587.00K | 1.13M | 303.00K | 6.00K |
| Total Current Assets | 11.33M | 8.59M | 5.62M | 2.93M | 312.00K | 96.00K |
| Property, Plant & Equipment | 46.00K | 74.00K | 124.00K | 22.00K | 71.00K | 117.00K |
| Other Long-Term Assets | 5.00K | |||||
| Total Assets | 11.38M | 8.67M | 5.74M | 2.96M | 383.00K | 218.00K |
| Accounts Payable | 526.00K | 1.84M | 897.00K | 1.41M | 1.29M | 57.00K |
| Accrued Expenses | 530.00K | 750.00K | 691.00K | 1.27M | 36.00K | 1.27M |
| Short-Term Debt | 602.00K | 3.50M | ||||
| Current Portion of Leases | 44.00K | 56.00K | 48.00K | 14.00K | 57.00K | 47.00K |
| Other Current Liabilities | 3.00K | 5.00K | ||||
| Total Current Liabilities | 1.10M | 2.64M | 1.64M | 2.70M | 1.99M | 4.88M |
| Long-Term Leases | 15.00K | 71.00K | 14.00K | 67.00K | ||
| Other Long-Term Liabilities | 124.00K | |||||
| Total Liabilities | 1.10M | 2.66M | 1.71M | 2.70M | 2.01M | 5.07M |
| Common Stock | 228.00K | |||||
| Additional Paid-In Capital | 65.62M | 57.70M | 43.77M | 31.79M | 16.87M | 10.20M |
| Retained Earnings | -55.34M | -51.70M | -39.74M | -31.53M | -18.50M | -15.28M |
| Shareholders' Equity | 10.28M | 6.01M | 4.03M | 259.00K | -1.62M | -4.85M |
| Total Liabilities & Equity | 11.38M | 8.67M | 5.74M | 2.96M | 383.00K | 218.00K |
| Total Debt | 44.00K | 71.00K | 119.00K | 14.00K | 673.00K | 3.61M |
| Net Cash (Debt) | 10.90M | 8.16M | 4.91M | 1.79M | -664.00K | -3.52M |
| Net Cash Per Share | 13.04 | 83.11 | ||||
| Filing Date Shares Outstanding | 2.19M | 1.45M | 18.76K | 26.73M | 22.77M | |
| Total Common Shares Outstanding | 2.19M | 497.69K | 18.77K | 26.73M | 22.77M | |
| Working Capital | 10.23M | 5.95M | 3.98M | 237.00K | -1.68M | -4.78M |
| Book Value Per Share | 4.70 | 12.07 | 214.85 | -0.06 | -0.21 | |
| Tangible Book Value | 10.28M | 6.01M | 4.03M | 259.00K | -1.62M | -4.85M |
| Tangible Book Value Per Share | 4.70 | 12.07 | 214.85 | -0.06 | -0.21 | |
| Machinery | 37.00K | 37.00K | 34.00K | 34.00K | 26.00K | 23.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -9.66M | -11.96M | -8.21M | -13.04M | -3.22M | -1.56M |
| Depreciation & Amortization | 3.00K | 4.00K | 4.00K | 4.00K | 50.00K | 49.00K |
| Other Amortization | 2.10M | 217.00K | 150.00K | |||
| Stock-Based Compensation | 596.00K | 793.00K | 148.00K | 388.00K | 25.00K | |
| Other Operating Activities | 52.00K | 48.00K | -108.00K | -129.00K | 325.00K | -50.00K |
| Change in Accounts Payable | -992.00K | 663.00K | -387.00K | 2.16M | 897.00K | 54.00K |
| Change in Other Net Operating Assets | -415.00K | 262.00K | -61.00K | -479.00K | 618.00K | 509.00K |
| Operating Cash Flow | -10.41M | -10.19M | -8.61M | -8.99M | -1.08M | -847.00K |
| Capital Expenditures | -3.00K | -3.00K | -8.00K | -3.00K | ||
| Investing Cash Flow | -3.00K | -3.00K | -8.00K | -3.00K | ||
| Short-Term Debt Issued | 1.44M | 1.53M | 500.00K | |||
| Total Debt Issued | 1.44M | 1.53M | 500.00K | |||
| Short-Term Debt Repaid | -195.00K | -280.00K | ||||
| Total Debt Repaid | -195.00K | -280.00K | ||||
| Net Debt Issued (Repaid) | 1.25M | 1.25M | 500.00K | |||
| Issuance of Common Stock | 17.83M | 15.56M | 13.87M | 12.26M | 100.00K | |
| Repurchase of Common Stock | -1.00K | -1.00K | -1.00K | -124.00K | ||
| Other Financing Activities | -1.59M | -2.17M | -2.03M | -2.71M | -124.00K | |
| Financing Cash Flow | 16.24M | 13.39M | 11.83M | 10.80M | 1.01M | 600.00K |
| Net Cash Flow | 5.83M | 3.20M | 3.22M | 1.80M | -81.00K | -247.00K |
| Free Cash Flow | -10.42M | -10.19M | -8.61M | -9.00M | -1.09M | -847.00K |
| Free Cash Flow Per Share | -12.46 | -103.80 | ||||
| Levered Free Cash Flow | -6.59M | -5.47M | -5.55M | -5.25M | -1.81M | -1.61M |
| Unlevered Free Cash Flow | -6.59M | -5.47M | -5.55M | -6.05M | -1.62M | -1.42M |
| Cash Interest Paid | 33.00K | |||||
| Change in Working Capital | -1.41M | 925.00K | -448.00K | 1.68M | 1.51M | 563.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 3.34M | 2.50M | 7.40M | 1.73M | ||
| Enterprise Value | -7.56M | -1.47M | 2.79M | -1.73M | ||
| Last Close Price | 1.53 | 6.91 | 394.32 | 16,674.51 | ||
| PB Ratio | 0.33 | 0.42 | 1.83 | 6.70 | ||
| P/TBV Ratio | 0.33 | 0.42 | 1.83 | 6.70 | ||
| Debt / Equity Ratio | 0.00 | 0.01 | 0.03 | 0.05 | -0.41 | -0.74 |
| Net Debt / Equity Ratio | -1.06 | -1.36 | -1.22 | -6.93 | -0.41 | -0.73 |
| Net Debt / EBITDA Ratio | 1.13 | 0.68 | 0.60 | 0.16 | -0.30 | -3.33 |
| Net Debt / FCF Ratio | 1.05 | 0.80 | 0.57 | 0.20 | -0.61 | -4.16 |
| Quick Ratio | 9.95 | 3.11 | 3.07 | 0.67 | 0.01 | 0.02 |
| Current Ratio | 10.30 | 3.25 | 3.43 | 1.09 | 0.16 | 0.02 |
| Return on Equity (ROE) | -142.02% | -238.17% | -382.52% | |||
| Return on Assets (ROA) | -70.93% | -103.93% | -118.39% | -416.93% | -465.68% | -226.54% |
| Return on Capital Employed (ROCE) | -94.10% | -198.90% | -200.70% | -4,300.00% | 139.00% | 22.80% |
| Earnings Yield | -755.18% | -478.65% | -110.90% | -751.78% | ||
| FCF Yield | -311.47% | -407.91% | -116.36% | -518.87% |